Seattle Genetics

  www.seattlegenetics.com
  www.seattlegenetics.com

Seattle Genetics Video

Provided by employer [?]

Loading...

Seattle Genetics – Why Work For Us?

Advancing Breakthrough Therapies for Cancer

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. ADCs are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.

First in a New Class of ADCs

The company’s first ADC product ADCETRIS® (brentuximab vedotin) is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. The approval of ADCETRIS makes it the first in a new class of ADCs.

To expand on the ADCETRIS opportunity, we are conducting a broad clinical development program to evaluate its therapeutic potential in earlier lines of its approved indications as well as in a range of other lymphoma and non-lymphoma settings.

Seattle Genetics is jointly developing ADCETRIS in collaboration with Takeda Pharmaceutical Company. Under the collaboration, Seattle Genetics has full commercialization rights to ADCETRIS in the United States and Canada. Takeda has exclusive rights to commercialize the product candidate in all other countries.

Advancing Our Robust ADC Pipeline

In addition to ADCETRIS, we are advancing a robust ADC product pipeline designed to address the unmet medical needs of people with cancer. Our strong research and development capabilities are our engine for innovation and 
long-term growth. Seattle Genetics’ ADC technology is also employed by collaborators and, across both internal and collaborator programs, there are more than 20 ADCs in clinical development using our proprietary approach to empowering antibodies.

Seattle Genetics was founded in 1998 and is headquartered in Bothell, Washington, a suburb of Seattle. The company completed an initial public offering in March 2001, and is traded on the Nasdaq Stock Market under the symbol SGEN. We have more than 600 employees throughout the United States, all with a passion for helping people living with cancer.

Improving the lives of people with cancer through innovative and empowered antibody-based therapies

We have built a strong corporate culture around the values of integrity, scientific excellence, teamwork, innovation and mutual respect. Seattle Genetics embodies an entrepreneurial spirit that advances breakthrough therapies, which is why we are an acknowledged leader today in antibody-drug conjugate technology.

Values

Passion for helping patients
Revolutionizing therapy for people living with cancer

Integrity
Honesty, respect and trust guide us

Scientific excellence
Premier science empowers our passion

Teamwork & mutual respect
Shared dedication drives successful collaborations

Innovation
Entrepreneurial spirit advances breakthrough therapies

Great work environment
Commitment and opportunity inspire purposeful contribution

We value integrity, scientific excellence, teamwork, innovation and mutual respect

At Seattle Genetics, we are passionate about positively impacting the lives of people with cancer. Team members bring that enthusiasm to everything we do, striving to attain individual goals while recognizing the power of working collaboratively to realize Seattle Genetics' vision of improving patient outcomes. Put your passion to work at Seattle Genetics.

As a company leading the field in developing antibody-drug conjugates, Seattle Genetics fosters an environment that recognizes the challenges of breaking new ground by creating opportunities for focused intellectual curiosity and professional growth. Our state-of-the art facility gives our team members the resources to succeed. Located in Bothell's Canyon Park area, Seattle Genetics is close to major highways, dining and shopping.

Seattle Genetics provides a competitive compensation and benefits package (including stock options, medical, dental, vision, life and disability insurance, employee stock purchase plan and 401(k) plan).

If you are passionate about bringing the best of yourself to everything you do, Seattle Genetics offers challenges, opportunities and rewards. We want to hear from you!

Living in the Pacific Northwest

With ready access to Puget Sound, lakes and mountains, residents of the Seattle area enjoy skiing, hiking, boating and a world-class trail system for bicycling, running or walking. A robust and diverse cultural scene includes multiple theater, music, dance, art and sports venues, providing access to the best of local, national and international talent. The Pacific Northwest is rich in scientific research and discovery, and home to leading academic and research institutions, including the University of Washington and Fred Hutchinson Cancer Research Center. Proximity to Vancouver, B.C., the San Juan Islands, Portland, Oregon and the Olympic and Cascade Mountains makes it easy to play as hard as you work. At Seattle Genetics, you’ll find a rewarding career in a place you will be proud to call home.

Seattle Genetics Reviews

17 Reviews
2.9
17 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Seattle Genetics President and CEO Clay B. Siegall
Clay B. Siegall
12 Ratings
  1.  

    Great science and corporate culture

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee in Bothell, WA (US)
    Current Employee - Anonymous Employee in Bothell, WA (US)

    I have been working at Seattle Genetics full-time (more than 5 years)

    Pros

    The CEO and upper management foster a company culture that is very patient focused. The work environment is supportive, and benefits are good. Great science, people are very passionate about the work, and there is a high amount of integrity in the way things are done.

    Cons

    It can take time to achieve upward mobility due a relatively low turnover rate. Career development is treated by some managers as a black box which the employee should have limited knowledge of.

    Recommends
    Neutral Outlook
    Approves of CEO

Seattle Genetics Interviews

Updated 16 Aug, 2014
Updated 16 Aug, 2014

Interview Experience

Interview Experience

50%
0%
50%

Getting an Interview

Getting an Interview

50%
50%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    RA III Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied through a recruiter. The process took 3 weeksinterviewed at Seattle Genetics.

    Interview Details

    I had had interviews with other major biotech companies which lasted over 4 hours each, so the ~1 hour interview that I had at Seattle Genetics was wonderfully refreshing. I was offered the position on the spot and just had to wait a couple of weeks for checks and references to make it final. The questions were straightforward and some were a repeat of the phone interview: tell us a bit about yourself, what did you do in the last lab you were in, etc. Also, questions such as: do you prefer working in a team or alone, what do you know about our company, and other run of the mill questions. If you haven't been working for a while be prepared to say how you have been keeping up your skills.

    Interview Questions
    • Why do you want to go from working in an academia to industry.   View Answer
    Accepted Offer
    Positive Experience
    Average Interview

Seattle Genetics Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Website www.seattlegenetics.com
Headquarters Bothell, WA
Size 500 to 999 Employees
Founded 1997
Type Company - Public (SGEN)
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (CAD) per year

To heck with verbs, Seattle Genetics is conjugating antibodies and drugs to fight cancer. The company's technologies use genetically engineered monoclonal antibodies (MAbs, or single source proteins) to trigger cell death in some cancers, but when they can't do it alone, Seattle Genetics pairs them up with drugs using its Antibody-Drug Conjugate (ADC) technology for a one-two punch. Its first product, Adcetris, gained FDA approval in 2011 for treatment of lymphoma in specific patient categories. With partner Millennium Pharmaceuticals, the company is working to expand... More

Work at Seattle Genetics? Share Your Experiences

Seattle Genetics

 
Click to Rate
or